{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:23:49Z","timestamp":1772306629498,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ejps.2013.01.015","type":"journal-article","created":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T18:04:30Z","timestamp":1360260270000},"page":"51-56","source":"Crossref","is-referenced-by-count":10,"title":["Site dependent intestinal absorption of darunavir and its interaction with ketoconazole"],"prefix":"10.1016","volume":"49","author":[{"given":"Jef","family":"Stappaerts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2013.01.015_b0005","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1208\/ps010418","article-title":"Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4","volume":"1","author":"Achira","year":"1999","journal-title":"AAPS Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.01.015_b0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/bdd.1809","article-title":"Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5","volume":"33","author":"Arakawa","year":"2012","journal-title":"Biopharm. Drug. Dispos."},{"key":"10.1016\/j.ejps.2013.01.015_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2013.01.015_b0020","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/QAD.0b013e3280da8ba8","article-title":"Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients","volume":"21","author":"Autar","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2013.01.015_b0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/dmd.30.10.1059","article-title":"Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys","volume":"30","author":"Balani","year":"2002","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2013.01.015_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp0600687","article-title":"Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine","volume":"4","author":"Berggren","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2013.01.015_b0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijpharm.2006.12.011","article-title":"In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation","volume":"336","author":"Brouwers","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.01.015_b0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejps.2011.12.007","article-title":"In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives","volume":"45","author":"Buckley","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.01.015_b0045","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1440-1681.2007.04691.x","article-title":"Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum","volume":"34","author":"Canaparo","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejps.2013.01.015_b0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/mp0499104","article-title":"Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability","volume":"2","author":"Cao","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2013.01.015_b0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1023\/A:1023891320858","article-title":"P-glycoprotein attenuating effect of human intestinal fluid","volume":"20","author":"Deferme","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.01.015_b0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.18433\/J3SG66","article-title":"The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole","volume":"11","author":"Elsherbiny","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.01.015_b0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejps.2006.04.010","article-title":"Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells","volume":"29","author":"Englund","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.01.015_b0070","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00498250801986951","article-title":"Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family","volume":"38","author":"Hagenbuch","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2013.01.015_b0075","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1124\/dmd.111.038323","article-title":"Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2)","volume":"39","author":"Haslam","year":"2011","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2013.01.015_b0080","doi-asserted-by":"crossref","unstructured":"Holmstock, N., Annaert, P., Augustijns, P., 2012. Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice. Drug. Metab. Dispos. 40, 1473\u20131477.","DOI":"10.1124\/dmd.112.044677"},{"key":"10.1016\/j.ejps.2013.01.015_b0085","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1124\/dmd.110.032771","article-title":"In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal p-glycoprotein by ritonavir causing increased darunavir absorption","volume":"38","author":"Holmstock","year":"2010","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2013.01.015_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int. J. pharm."},{"key":"10.1016\/j.ejps.2013.01.015_b0095","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.bcp.2006.07.020","article-title":"Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin a absorption, and effect of dexamethasone in small intestine of mice","volume":"72","author":"Jin","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2013.01.015_b0100","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/jpet.301.2.586","article-title":"Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat","volume":"301","author":"Li","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2013.01.015_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2010.10.017","article-title":"Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion","volume":"403","author":"Li","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2013.01.015_b0110","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/dmd.108.020859","article-title":"Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein two in male and female rats","volume":"36","author":"MacLean","year":"2008","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2013.01.015_b0115","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ejps.2010.09.007","article-title":"Regional absorption of fexofenadine in rat intestine","volume":"41","author":"MacLean","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.01.015_b0120","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1124\/dmd.107.019687","article-title":"Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats","volume":"36","author":"Mitschke","year":"2008","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.ejps.2013.01.015_b0125","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1023\/A:1026183200740","article-title":"P-glycoprotein increases from proximal to distal regions of human small intestine","volume":"20","author":"Mouly","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.01.015_b0130","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/138920011798356999","article-title":"In silico, in vitro and in situ models to assess interplay between CYP3A and P-gp","volume":"12","author":"Mudra","year":"2011","journal-title":"Curr. Drug. Metab."},{"key":"10.1016\/j.ejps.2013.01.015_b0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejps.2011.04.007","article-title":"P-glycoprotein limits the absorption of the antiHIV drug zidovudine through rat intestinal segments","volume":"43","author":"Quevedo","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.01.015_b0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00003088-200746090-00002","article-title":"Clinical pharmacokinetics of darunavir","volume":"46","author":"Rittweger","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2013.01.015_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2125.2008.03191.x","article-title":"Pharmacokinetics of darunavir\/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers","volume":"66","author":"Sekar","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2013.01.015_b0150","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/jps.20538","article-title":"In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance","volume":"95","author":"Strelevitz","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.01.015_b0155","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1124\/dmd.31.10.1235","article-title":"Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine","volume":"31","author":"Takara","year":"2003","journal-title":"Drug. Metab. Dispos."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T18:15:00Z","timestamp":1714932900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098713000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0928098713000560"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2013.01.015","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}